Dr. Graff-Radford has received research funding for his Memory Disorders Lab from a variety of organizations, including the National Institutes of Health (NIH), the National Institute on Aging and pharmaceutical companies. The institutions and their funded studies include:
National Institutes of Health (NIH)
- A Study of Change in Imaging Biomarkers of Dementia with Lewy Bodies (DLB) and Associations with Cognitive and Functional Decline — This study gathers radiological and fluid biomarkers from people with DLB.
- Alzheimer's Clinical Trials Consortium (ACTC) — A National Institute on Aging-funded consortium that carries out clinical trials in Alzheimer's disease.
- Alzheimer's Disease Neuroimaging Initiative (ADNI) — A national group formed to study data to define the progression of Alzheimer's disease.
- Dominantly Inherited Alzheimer Network (DIAN) — A study following families with dominantly inherited Alzheimer's disease.
- Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) — An observational study to look at disease progression in adults with early onset Alzheimer's disease.
- Advancing Research & Treatment for Frontotemporal Lobar Degeneration (ARTFL) and Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) study — The ARTFL LEFFTDS Longitudinal FTD (ALLFTD) consortium recruits and follows familial and nonfamilial cases of people with frontotemporal dementia.
- The A4 Study — Funded with Eli Lilly, this study investigates the effect of anti-amyloid treatment for people with normal cognition who have a positive amyloid PET scan.
Lewy Body Dementia Association
- Lewy Body Dementia Research Center of Excellence — A consortium funded by the Lewy Body Dementia Association to study Lewy body dementia.
- The ABBVIE M15-566/M15-570 Study — Study to determine if using a monoclonal antibody tau antibody delays progression of mild Alzheimer's disease.